This compound is primarily utilized in the pharmaceutical industry as a chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its specific structure, featuring both phenyl and chlorophenyl groups, makes it valuable in the development of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. Additionally, it serves as a building block in the creation of ligands for asymmetric catalysis, enhancing the efficiency and selectivity of chemical reactions in organic synthesis. Its application extends to research settings where it is used to study receptor interactions and develop new therapeutic agents with improved efficacy and reduced side effects.